Skip to content

East Shizuoka TirzepATidE study

East Shizuoka TirzepATidE study - ESTATE study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053671
Enrollment
150
Registered
2024-03-01
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

None listed

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes undergoing treatment with tirzepatide

Exclusion criteria

Exclusion criteria: Patients who are inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Glycemic control

Secondary

MeasureTime frame
Body weight change

Countries

Japan

Contacts

Public ContactTakashi Nomiyama

Juntendo University Shizuoka Hospital Department of Diabetes, Endocrinology and Metabolism

nomiyama@juntendo.ac.jp+81-55-948-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026